我的随身电脑——华硕Eee PC 1000HE上网本使用体会

瘦客户机 瘦客户机对于目前的医疗保健、金融、教育及其它行业来说．是一项良好的解决方案。不但经济实惠,也更便于IT管理人员进行管理。我们评测的是实达WT-8040瘦客户机。     

Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum

In several autoimmune disorders, including rheumatoid arthritis (RA), autoantibodies are thought to be the driving force of pathogenicity. Glycosylation of the Fc-part of human Igs is known to modulate biological activity. Hitherto, glycosylation of human IgG-Fc has been analyzed predominantly at the level of total serum IgG, revealing reduced galactosylation in RA. Given the pathogenic relevance of autoantibodies in RA, we wished, in the present study, to address the question whether distinct Fc-glycosylation features are observable at the level of antigen-specific IgG subpopulations. For this purpose, we have developed a method for the microscale purification and Fc-glycosylation analysis of anti-citrullinated peptide antibodies (ACPA). ACPA represent a group of autoantibodies that occur with unique specificity in RA patients. Their presence is associated with increased inflammatory disease activity and rapid joint destruction. Results indicate that ACPA of the IgG1 subclass vary considerably from total serum IgG1 with respect to Fc-galactosylation, with galactosylation being higher on ACPA than on serum IgG1 for some patients, while other patients show higher galactosylation on serum IgG1 than on ACPA. Using this method, studies can be performed on the biological and clinical relevance of ACPA glycosylation within RA patient cohorts.     

Coulomb interactions in Ga LMIS

For low emission currents from around 1 microA Ga liquid-metal ion sources (LMIS) produce fine optically bright ion beams that are strongly limited by the Coulomb particle-particle interactions. We present computations of the energy spread, the beam virtual crossover size, and beam brightness based on direct numerical integration of the equation of motion in a numerically calculated field for a number of dimensions of the emission tip. The Coulomb particle-particle interactions are included into the calculation of ion beam evolution. A comparison with experimental data allows to estimate the tip size.     

Motion estimation of skeletonized angiographic images using elastic registration

An approach for estimating the motion of arteries in digital angiographic image sequences is proposed. Binary skeleton images are registered using an elastic registration algorithm in order to estimate the motion of the corresponding arteries. This algorithm operates recursively on the skeleton images by considering an autoregressive (AR) model of the deformation in conjunction with a dynamic programming (DP) algorithm. The AR model is used at the pixel level and provides a suitable cost function to DP through the innovation process. In addition, a moving average (MA) model for the motion of the entire skeleton is used in combination with the local AR model for improved registration results. The performance of this motion estimation method is demonstrated on simulated and real digital angiographic image sequences. It is shown that motion estimation using elastic registration of skeletons is very successful especially with low contrast and noisy angiographic images.     

Network flow and 2-satisfiability

We present two algorithms for network flow on networks with infinite capacities and finite integer supplies and demands. The first algorithm runs inO(mK) time on networks withm edges, whereK=O(m²/log⁴ m) is the value of the optimal flow, and can also be applied to the capacitated case by lettingK be the sum of thefinite capacities alone. The second algorithm runs inO(wm logK) time for arbitraryK, where w is a new parameter, thewidth of the network. These algorithms as well as other uses of the notion of width lead to results for several questions on the 2-satisfiability problem: minimizing the weight of a solution, finding the transitive closure, recognizing partial solutions, enumerating all solutions. The results have applications to stable matching, wherew corresponds to the number of people andm to the instance size (usuallym w²).     

Developments in proton MR spectroscopic imaging of prostate cancer

Magnetic Resonance Materials in Physics, Biology and Medicine - In this paper, we review the developments of 1H-MR spectroscopic imaging (MRSI) methods designed to investigate prostate cancer,...     

Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis

Introduction: Oral phosphate binders are the main stay of treatment of hyperphosphatemia. Adherence rates to ferric citrate, a recently approved phosphate binder, are unknown. Methods: We conducted a post‐hoc analysis to evaluate whether adherence rates were different for ferric citrate vs. active control in 412 subjects with end stage kidney disease (ESKD) who were randomized to ferric citrate vs. active control (sevelamer carbonate and/or calcium acetate). Adherence was defined as percent of actual number of pills taken to total number of pills prescribed. Findings: There were no significant differences in baseline characteristics including gender, race/ethnicity, and age between the ferric citrate and active control groups. Baseline phosphorus, calcium, and parathyroid hormone levels were similar. Mean (SD) adherence was 81.4% (17.4) and 81.7% (15.9) in the ferric citrate and active control groups, respectively (P = 0.88). Adherence remained similar between both groups after adjusting for gender, race/ethnicity, age, cardiovascular disease (CVD), and diabetic nephropathy (mean [95% CI]: 81.4% [78.2, 84.6] and 81.5% [77.7, 85.2] for ferric citrate and active control, respectively). Gender, race/ethnicity, age, and diagnosis of diabetic nephropathy did not influence adherence to the prescribed phosphate binder. Subjects with CVD had lower adherence rates to phosphate binder; this was significant only in the active control group. Discussion: Adherence rates to the phosphate binder, ferric citrate, were similar to adherence rates to active control. Similar adherence rates to ferric citrate are notable since tolerance to active control was an entry criteria and the study was open label. Gender, race/ethnicity, nor age influenced adherence.     

Application of a hot-melt granulation process to enhance fenofibrate solid dose manufacturing

Evaluation of hot-melt granulation of fenofibrate and croscarmellose sodium and its cooling time for the molten mass in a ratio of 55:45 was conducted to assess the manufacturing process capability to produce an acceptable granulation which flows well on Korsch PH300 tablet compression machine. The formation of the drug-polymer eutectic mixture was investigated by differential scanning calorimetry, scanning electron microscopy and X-ray powder diffraction. The physical properties of the hot-melt was determined by examining the milled blocks after solidification and milling after cooling periods of 10, 20 and 30 d. The milled material was assessed for the effect of hold time of the blend on the solid dose compression characteristics. The impact of cooling on the processing of the blocks was assessed after 10, 20 and 30 d of cooling. The study suggests that after the hot-melt formed the fenofibrate crystallized independently and a solid solution with croscarmellose sodium was not formed. The age of the blocks determined the hardness of the crystals, changing the processing nature of the granules with respect to compression and powder flow characteristics. The blocks processed after 20 d and beyond produced granules with a characteristic suitable for holding the blend for 14 d in the bin with no impact on flow properties and compressibility of the blend. There was no chipping, capping, sticking or picking observed and a higher compression speed was achieved.